GO:0004197 cysteine-type endopeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004197 cysteine-type endopeptidase activity describes a molecular function in which a cysteine residue in the enzyme active site acts as a nucleophile to hydrolyze internal peptide bonds in proteins [1,2].
• This activity is central to apoptosis, inflammation, lysosomal protein turnover, and plant developmental processes such as vacuolar processing [2,3].
• Key gene families include caspases (CASP1, CASP3, CASP8), cathepsins (CTSB, CTSC, CTSS), calpains (CAPN1, CAPN2), and plant vacuolar processing enzymes (VPEs) [2,3,5].
• Dysregulated cysteine-type endopeptidase activity is implicated in cancer, neuropathic pain, retinoblastoma, and smoking-related ocular pathology [1,4,5,7,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of cysteine protease function in disease contexts [1,3,5].
• EDITGENE provides end-to-end CRISPR services including KO, point mutation, knock-in, overexpression, library screening, and bioinformatics for cysteine protease research [1,4,6].
Description
Cysteine-type endopeptidase activity (GO:0004197) is a molecular function defined by the catalysis of internal alpha-peptide bond hydrolysis using a cysteine residue as the active-site nucleophile [1,2]. This mechanism distinguishes cysteine proteases from serine, aspartic, and metalloproteases, and it underlies the activity of diverse enzyme families including caspases, cathepsins, calpains, and vacuolar processing enzymes [2,3,5]. Researchers study this activity because it governs fundamental processes such as programmed cell death, immune signaling, lysosomal degradation, and plant development [2,3]. In humans, dysregulated cysteine-type endopeptidase activity contributes to cancer progression, neuropathic pain, and ocular pathologies [1,4,5,7,8]. In plants, vacuolar processing enzymes with this activity are essential for seed development, senescence, and defense responses. Understanding the genes, regulation, and disease relevance of GO:0004197 is therefore critical for both basic biology and therapeutic development [1,2,3].
cysteine-type endopeptidase activity At A Glance
| GO ID | GO:0004197 |
|---|---|
| GO term | cysteine-type endopeptidase activity |
| Ontology | molecular_function |
| Synonym | caspase activity; lysosomal cysteine-type endopeptidase; metacaspase activity; thiol endopeptidase activity |
| Major function | Hydrolysis of internal alpha-peptide bonds using a cysteine nucleophile |
| Catalytic residue | Cysteine sulfhydryl group at the active center |
| Substrate specificity | Internal peptide bonds in polypeptide chains |
| Representative families | Caspases, cathepsins, calpains, vacuolar processing enzymes |
| Disease relevance | Cancer, neuropathic pain, retinoblastoma, ocular pathology |
What Is GO:0004197?
GO:0004197 cysteine-type endopeptidase activity is defined by QuickGO as the catalysis of hydrolysis of internal alpha-peptide bonds in a polypeptide chain through a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile [1,2]. In simpler terms, it is a protein-cutting activity where a cysteine amino acid in the enzyme performs the chemical attack that breaks the peptide bond. This activity is synonymous with caspase activity, lysosomal cysteine-type endopeptidase, metacaspase activity, and thiol endopeptidase activity [2,3].
Why Is cysteine-type endopeptidase activity Important in Cell Biology?
Cysteine-type endopeptidase activity is essential for life because it controls protein degradation, cell death, and immune signaling [2,3]. In humans, caspases with this activity execute apoptosis and inflammatory pyroptosis, while cathepsins mediate lysosomal turnover and antigen presentation [3,5]. In plants, vacuolar processing enzymes regulate seed development and stress responses. Dysregulation of these enzymes is linked to cancer, neuropathic pain, retinoblastoma, and smoking-related ocular changes [1,4,5,7,8]. Therefore, understanding GO:0004197 is critical for disease mechanism research and therapeutic targeting [1,2,3].
• Executes programmed cell death through caspase family proteases.
• Mediates inflammatory signaling and pyroptosis in immune cells.
• Controls lysosomal protein turnover via cathepsins.
• Regulates plant development through vacuolar processing enzymes.
• Contributes to cancer progression and chemoresistance [1,4].
• Is implicated in neuropathic pain mechanisms.
• Plays a role in retinoblastoma pathogenesis.
• Is altered in chronic smoking-related ocular pathology.
• Provides targets for CRISPR-based functional genomics [1,3,5].
• Enables bioinformatics-driven biomarker discovery [4,6,7].
What Happens During cysteine-type endopeptidase activity?
Substrate recognition and active-site engagement
In simple terms: The enzyme finds and binds its target protein at a specific sequence.
Cysteine-type endopeptidases recognize substrate sequences through extended active-site clefts that position the scissile peptide bond near the catalytic cysteine [2,3]. In caspases, this recognition is highly specific for aspartate residues at the P1 position, ensuring precise cleavage of apoptotic substrates. In plant vacuolar processing enzymes, substrate recognition is tuned to vacuolar processing signals.
Nucleophilic attack and peptide bond cleavage
In simple terms: The cysteine residue chemically attacks the peptide bond and breaks it.
The sulfhydryl group of the catalytic cysteine acts as a nucleophile, attacking the carbonyl carbon of the scissile peptide bond to form a covalent acyl-enzyme intermediate [1,2]. This step is facilitated by a histidine general base and an asparagine or aspartate residue that orient the cysteine and stabilize the transition state. Hydrolysis of the intermediate releases the cleaved peptide products.
Caspase activation cascades
In simple terms: Caspases activate each other in a chain reaction to amplify protein cutting.
Initiator caspases such as CASP8 and CASP9 are activated through dimerization and cleavage, then cleave effector caspases including CASP3 and CASP7. This cascade amplifies cysteine-type endopeptidase activity and ensures rapid substrate proteolysis during apoptosis. Inflammatory caspases such as CASP1 are activated by inflammasome platforms and cleave gasdermin D to induce pyroptosis.
Lysosomal and vacuolar proteolysis
In simple terms: Inside acidic compartments, these enzymes digest proteins into smaller pieces.
Cathepsins such as CTSB, CTSC, and CTSS function optimally at acidic pH within lysosomes and endolysosomes. Plant vacuolar processing enzymes carry out similar roles in the vacuole, processing storage proteins and mediating cell death during development. This compartmentalization prevents unwanted proteolysis in the cytosol.
Substrate turnover and downstream signaling
In simple terms: Cutting proteins changes their function and sends signals to the cell.
Cleavage of substrates by cysteine-type endopeptidases can activate or inactivate signaling proteins, remodel the cytoskeleton, and trigger DNA fragmentation [3,5]. For example, caspase-mediated cleavage of gasdermin D releases an N-terminal fragment that forms membrane pores during pyroptosis. These downstream events link GO:0004197 to inflammation, cell death, and tissue remodeling [3,5].
Key Genes Involved in GO:0004197 cysteine-type endopeptidase activity
The following genes encode proteins with cysteine-type endopeptidase activity or directly regulate this function across human and plant systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP1 | Inflammatory caspase; cleaves gasdermin D | Pyroptosis and neuropathic pain models |
| CASP3 | Executioner caspase; cleaves apoptotic substrates | Apoptosis and cancer research |
| CASP8 | Initiator caspase; activates downstream caspases | Apoptosis and immune signaling |
| CASP9 | Initiator caspase; apoptosome-dependent activation | Intrinsic apoptosis research |
| CTSB | Lysosomal cysteine protease | Cancer invasion and lysosomal turnover |
| CTSC | Lysosomal cysteine protease | Immune regulation and tissue remodeling |
| CTSS | Lysosomal cysteine protease | Antigen presentation and inflammation |
| CAPN1 | Calcium-dependent cysteine protease | Cytoskeletal remodeling and neurodegeneration |
| CAPN2 | Calcium-dependent cysteine protease | Cell migration and apoptosis |
| VPE1 | Plant vacuolar processing enzyme | Seed development and senescence |
| VPE2 | Plant vacuolar processing enzyme | Stress responses and defense |
| ATG4B | Cysteine protease for autophagy | Autophagy regulation and cancer |
| SENP1 | Cysteine protease for SUMOylation | Gene regulation and cancer |
| USP7 | Cysteine protease for deubiquitination | Oncogenesis and DNA repair |
| FBXO32 | E3 ligase related to proteolysis | Muscle atrophy and diabetes |
| TRIM63 | E3 ligase related to proteolysis | Muscle wasting and metabolism |
| CASP7 | Effector caspase | Apoptosis amplification |
How Is cysteine-type endopeptidase activity Regulated?
Cysteine-type endopeptidase activity is tightly regulated at multiple levels. Caspases are controlled by inhibitor of apoptosis proteins (IAPs) and by phosphorylation. Cathepsins are regulated by pH, endogenous inhibitors such as cystatins, and trafficking to lysosomes. In plants, vacuolar processing enzymes are regulated by developmental cues and stress signals. In disease contexts, bioinformatics analyses have identified ncRNA-mRNA axes that modulate cysteine protease expression in breast cancer. Pyroptosis-related gene networks involving caspases are altered in neuropathic pain models. Additionally, proteomic studies in chronic smokers reveal perturbations in aqueous humor proteins including protease regulators.
cysteine-type endopeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CASP1 | Neuropathic pain and pyroptosis | KO and point-mutation models in rat or mouse neurons |
| CASP3 | Cancer apoptosis resistance | Knockout and overexpression in cancer cell lines [1,3] |
| CTSB | Tumor invasion and lysosomal turnover | Knock-in of tagged CTSB in cancer cells |
| VPE1 | Plant development and stress | Knockout in Arabidopsis or crop models |
| SENP1 | Breast cancer and SUMOylation | Overexpression and KO in breast cancer lines |
Cysteine-type endopeptidases in cancer
Cysteine proteases such as cathepsins and caspases contribute to tumor progression, invasion, and resistance to apoptosis [1,4]. Network pharmacology and experimental validation have shown that natural compounds can modulate cysteine-type endopeptidase activity in gastric cancer. Bioinformatics analyses of breast cancer have identified FKBP-related ncRNA-mRNA axes that regulate protease expression. In retinoblastoma, key biomarkers include cysteine protease pathway components.
Cysteine-type endopeptidases in neuropathic pain and neuroinflammation
Pyroptosis-related genes, including CASP1 and other cysteine-type endopeptidases, are differentially expressed in male rats with spared nerve injury-induced neuropathic pain. Terminally differentiated cytotoxic CD4+ T cells clonally expanded in brain lesions of radiation-induced brain injury also express cytotoxic molecules that may involve cysteine protease activity. These findings link GO:0004197 to neuroinflammatory and pain mechanisms [3,5].
Cysteine-type endopeptidases in ocular and metabolic disease
Proteomic profiling of aqueous humor from chronic smokers reveals perturbations in proteins including protease regulators, suggesting a role for cysteine-type endopeptidases in smoking-related ocular pathology. In diabetes-related skeletal muscle lesions, bioinformatics and experimental validation have identified proteolysis-related genes such as FBXO32 and TRIM63. These studies highlight the broad disease relevance of cysteine-type endopeptidase activity [6,8].
From cysteine-type endopeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CASP1 cysteine protease activity drive pyroptosis in neuropathic pain? | Casp1 knockout rat or mouse |
| Is a specific caspase cleavage site required for apoptosis? | Point mutation at the cleavage site |
| Can a tagged cysteine protease be tracked in live cells? | Knock-in of fluorescent tag |
| Does overexpression of a cysteine protease promote cancer invasion? | Overexpression in cancer cell lines [1,4] |
| Which genes regulate cysteine protease expression in breast cancer? | CRISPR library screening and bioinformatics |
| How does a plant VPE contribute to seed development? | VPE knockout in Arabidopsis |
How to Study the cysteine-type endopeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic peptide assay | Cysteine protease catalytic activity | Caspase and cathepsin activity in lysates [2,3] |
| Active-site probe labeling | Active enzyme pool | Live-cell protease profiling |
| CRISPR knockout | Loss-of-function phenotype | Gene function in disease models [1,3,5] |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking and cleavage-site studies [2,3] |
| RNA-seq | Transcriptional changes | Pathway analysis in cancer and pain [4,5] |
| Proteomics | Protein abundance and cleavage products | Clinical sample profiling |
| Network pharmacology | Drug-target-pathway interactions | Natural compound mechanism studies |
| Bioinformatics biomarker discovery | Key gene identification | Retinoblastoma and metabolic disease [6,7] |
Protease activity assays
Fluorogenic peptide substrates and active-site probes are used to measure cysteine-type endopeptidase activity in cell lysates and live cells [2,3]. These assays can distinguish caspase, cathepsin, and calpain activities based on substrate specificity and inhibitors.
CRISPR-based functional genomics
CRISPR knockout and knock-in models enable loss-of-function and gain-of-function studies of cysteine protease genes [1,3,5]. Library screening can identify modifiers of cysteine-type endopeptidase activity in disease contexts such as cancer.
Bioinformatics and network analysis
Network pharmacology and bioinformatics analyses integrate gene expression, ncRNA, and pathway data to identify cysteine protease-related biomarkers [1,4,6,7]. These approaches have been applied to gastric cancer, breast cancer, retinoblastoma, and diabetes-related muscle lesions [1,4,6,7].
Proteomics and imaging
Mass spectrometry-based proteomics can quantify cysteine protease substrates and cleavage products in clinical samples such as aqueous humor. Fluorescent reporters and imaging track protease activation in live cells and tissues [3,5].
How CRISPR Can Be Used to Study GO:0004197 cysteine-type endopeptidase activity
Knockout
CRISPR knockout of cysteine protease genes such as CASP1, CASP3, or CTSB enables loss-of-function studies to determine their role in apoptosis, pyroptosis, and cancer progression [1,3,5]. Knockout models are essential for validating whether a candidate gene is causally involved in a disease phenotype.
Point Mutation
Point mutation of the catalytic cysteine or substrate cleavage sites can abolish or alter cysteine-type endopeptidase activity without affecting protein expression [2,3]. These models are critical for distinguishing catalytic activity from non-catalytic functions.
Knock-in
Knock-in of fluorescent or affinity tags allows tracking of cysteine protease localization and substrate interactions in live cells. Knock-in of disease-associated mutations can model human variants in isogenic backgrounds.
Overexpression
Overexpression of cysteine proteases such as SENP1 or CTSB can drive cancer cell invasion and survival phenotypes [1,4]. Overexpression models complement knockout studies by revealing gain-of-function effects.
How EDITGENE Supports cysteine-type endopeptidase activity Research
Researchers studying cysteine-type endopeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a disease phenotype or whether its catalytic activity is required for function. EDITGENE provides validated CRISPR models and bioinformatics services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cysteine-type endopeptidase activity research.
Frequently Asked Questions About cysteine-type endopeptidase activity
What is cysteine-type endopeptidase activity?
It is a molecular function (GO:0004197) where a cysteine residue in an enzyme active site acts as a nucleophile to hydrolyze internal peptide bonds in proteins [1,2].
What genes are involved in cysteine-type endopeptidase activity?
Key genes include CASP1, CASP3, CASP8, CASP9, CTSB, CTSC, CTSS, CAPN1, CAPN2, and plant VPE genes [2,3,5].
What diseases are linked to cysteine-type endopeptidase activity?
It is linked to cancer, neuropathic pain, retinoblastoma, and smoking-related ocular pathology [1,4,5,7,8].
How is cysteine-type endopeptidase activity regulated?
It is regulated by IAPs, pH, cystatins, developmental cues, and ncRNA-mRNA networks [2,3,4].
What is the difference between caspase and cathepsin activity?
Both are cysteine-type endopeptidases, but caspases function in apoptosis and inflammation while cathepsins work in lysosomal degradation [2,3].
How can I study cysteine-type endopeptidase activity in the lab?
Use fluorogenic peptide assays, active-site probes, CRISPR knockout, and proteomics [2,3,8].
What CRISPR models are available for cysteine protease research?
Knockout, point mutation, knock-in, and overexpression models are available from EDITGENE [1,3,5].
Is cysteine-type endopeptidase activity involved in plant biology?
Yes, vacuolar processing enzymes with this activity regulate seed development and stress responses.
What is the role of CASP1 in neuropathic pain?
CASP1 is a pyroptosis-related gene differentially expressed in neuropathic pain models.
How does bioinformatics help study cysteine proteases?
Network pharmacology and RNA-seq analyses identify biomarkers and pathways involving cysteine proteases [1,4,6,7].
Conclusion
GO:0004197 cysteine-type endopeptidase activity is a fundamental molecular function that drives protein cleavage in apoptosis, inflammation, lysosomal degradation, and plant development [2,3]. Its dysregulation is implicated in cancer, neuropathic pain, retinoblastoma, and ocular pathology [1,4,5,7,8]. CRISPR-based knockout, point mutation, knock-in, and overexpression models, combined with bioinformatics and proteomics, provide powerful tools to dissect these mechanisms [1,3,5]. EDITGENE offers comprehensive services to support this research and accelerate therapeutic discovery [1,4,6].
References
- 1. Tan XY et al.. 2023. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].. Zhongguo Zhong Yao Za Zhi 48(18):5056-5067 PMID: 37802848
- 2. Yamada K et al.. 2020. Vacuolar processing enzymes in the plant life cycle.. New Phytol 226(1):21-31 PMID: 31679161
- 3. Ma X et al.. 2024. Terminally differentiated cytotoxic CD4(+) T cells were clonally expanded in the brain lesion of radiation-induced brain injury.. CNS Neurosci Ther 30(3):e14682 PMID: 38499993
- 4. Xiong H et al.. 2020. FKBP-related ncRNA-mRNA axis in breast cancer.. Genomics 112(6):4595-4607 PMID: 32814092
- 5. Li W et al.. 2025. Identification of Pyroptosis-Related Genes in Male Rats with Spared Nerve Injury-Induced Neuropathic Pain.. J Pain Res 18:7029-7041 PMID: 41458185
- 6. Chen P et al.. 2025. Exploration of the mechanisms of HLWDD on skeletal muscle lesions under the influence of diabetes based on bioinformatics analysis and experimental validation.. Front Nutr 12:1586761 PMID: 41459066
- 7. Zhao XM et al.. 2021. Bioinformatics analysis of key biomarkers for retinoblastoma.. J Int Med Res 49(6):3000605211022210 PMID: 34187205
- 8. Amer R et al.. 2024. Aqueous humor perturbations in chronic smokers: a proteomic study.. Sci Rep 14(1):11279 PMID: 38760463
